|
Volumn 499, Issue 7459, 2013, Pages 394-396
|
Antibiotic resistance: The last resort
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA LACTAMASE;
CARBAPENEM;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTICS;
BACTERIAL DISEASE;
DISEASE CONTROL;
DISEASE PREVALENCE;
EPIDEMIOLOGY;
GLOBAL PERSPECTIVE;
HEALTH RISK;
MEDICINE;
MORTALITY;
PATHOGEN;
PUBLIC HEALTH;
RESEARCH PROGRAM;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL STRAIN;
ESCHERICHIA COLI;
HEALTH CARE PERSONNEL;
HOSPITAL;
HUMAN;
INFECTION CONTROL;
INTENSIVE CARE UNIT;
KLEBSIELLA INFECTION;
KLEBSIELLA PNEUMONIAE;
MICROBIOLOGY;
PHYSICIAN;
PNEUMONIA;
PRIORITY JOURNAL;
R FACTOR;
SWEDEN;
UNITED KINGDOM;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
BACTERIAL PROTEINS;
BETA-LACTAMASES;
CARBAPENEMS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
DRUG RESISTANCE, BACTERIAL;
ENTEROBACTERIACEAE;
EPIDEMIOLOGICAL MONITORING;
HUMANS;
INFECTION CONTROL;
INTERNATIONALITY;
ISRAEL;
KLEBSIELLA INFECTIONS;
KLEBSIELLA PNEUMONIAE;
PUBLIC HEALTH SURVEILLANCE;
SHOCK, SEPTIC;
UNITED STATES;
VANCOMYCIN;
|
EID: 84881119572
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/499394a Document Type: Article |
Times cited : (298)
|
References (7)
|